Form 4: CEL-SCI CSO Acquires Shares, Signals Confidence

CEL-SCI Corp.'s Chief Scientific Officer, Eyal Talor, acquired 260 shares of common stock at $9.20 per share.

Summary

• Eyal Talor, Chief Scientific Officer of CEL SCI CORP, acquired 260 shares of common stock.
• The transaction occurred on September 30, 2025, at a price of $9.20 per share.
• Following this acquisition, Eyal Talor directly beneficially owns 5,808 shares of common stock.
• The filing is a routine disclosure of an insider transaction.

Sentiment

Score: 7

Explanation: The acquisition of shares by a key executive is a positive signal of confidence, though the relatively small volume of shares acquired suggests a moderately positive impact rather than a significant one.

Positives

• The Chief Scientific Officer's acquisition of shares indicates management confidence in the company's future prospects.

Stakeholder Impact

• Shareholders may view the insider purchase as a positive sign of management's belief in the company's value and future performance.

Key Dates

Recommendation

While the Chief Scientific Officer's acquisition of shares indicates management confidence, the transaction volume of 260 shares is relatively small and does not provide a substantial basis for a strong buy or sell recommendation. Investors should consider this as a minor positive signal within their broader investment thesis for CEL SCI CORP.

Keywords

CEL SCI CORP, CVM, Eyal Talor, Insider Trading, Stock Acquisition, Form 4, Chief Scientific Officer